Free Trial

Athersys (ATHX) Insider Trading & Ownership

Athersys logo

Athersys (NASDAQ:ATHX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.03%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$102,256.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get ATHX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Athersys stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ATHX Insider Buying and Selling by Quarter

Athersys Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/17/2022Daniel A CamardoCEOBuy132,800$0.77$102,256.00  
(Data available from 1/1/2013 forward)

ATHX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Athersys includes Daniel A Camardo. Learn more on insiders at ATHX.

0.03% of Athersys stock is owned by insiders. Learn more on ATHX's insider holdings.

Athersys Key Executives

  • Mr. Daniel A. Camardo M.B.A. (Age 54)
    CEO, Secretary & Director
    Compensation: $796.81k
  • Ms. Z. Kasey Rosado (Age 49)
    Interim Chief Financial Officer
    Compensation: $1.51M
  • Ms. Maia A. Hansen M.B.A. (Age 54)
    M.S., Chief Operating Officer
    Compensation: $962.57k
  • Senthil Ranganathan Ph.D.
    Vice President of Technical Operations
  • Mr. David Russ M.B.A.
    Vice President of Supply Chain, Finance & Administration
  • Dr. Manal Morsy M.B.A.
    M.D., PH.D., Executive VP & Head of Global Regulatory Affairs
  • Dr. Robert Mays Ph.D.
    Executive VP, Head of Regenerative Medicine & Neuroscience Programs
  • Mr. Rakesh Ramachandran MS
    Head of Information Technology & Communications and VP
  • Dr. Sarah Busch Ph.D.
    VP of Regenerative Medicine & Head of Business Development
  • Ms. Ellen Gurley
    Manager of Corporate Communications and Investor Relations


This page (NASDAQ:ATHX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners